| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRI2262 |
| P698 | PubMed publication ID | 18274559 |
| P50 | author | Stephen T. Holgate | Q1547900 |
| P2093 | author name string | Riccardo Polosa | |
| P2860 | cites work | Allergen immunotherapy for asthma | Q24247724 |
| Development, migration, and survival of mast cells | Q24549674 | ||
| The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics | Q24561800 | ||
| Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma | Q24681031 | ||
| Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study | Q25255771 | ||
| Stem cell factor and its receptor c-Kit as targets for inflammatory diseases | Q28115994 | ||
| Recent advances in the management of asthma using leukotriene modifiers | Q28166742 | ||
| IL-13 effector functions | Q28180348 | ||
| Critical appraisal of antileukotriene use in asthma management | Q28211383 | ||
| Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge | Q28215560 | ||
| Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines | Q28218897 | ||
| IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts | Q28267624 | ||
| IL-31: a new link between T cells and pruritus in atopic skin inflammation | Q28295839 | ||
| IkappaB kinase-2-independent and -dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic | Q46975978 | ||
| Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin | Q47401930 | ||
| Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years | Q47606210 | ||
| Interferon-alphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Effect on disease control and systemic glucocorticosteroid dose | Q47718858 | ||
| Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo | Q47810986 | ||
| IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys | Q48080691 | ||
| A double-blind, placebo-controlled trial of montelukast in adult atopic eczema | Q48457370 | ||
| Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. | Q49032278 | ||
| The chromones: history, chemistry and clinical development. A tribute to the work of Dr R. E. C. Altounyan | Q50243483 | ||
| Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. | Q50621222 | ||
| Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice. | Q51001680 | ||
| Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. | Q51104473 | ||
| House dust mite allergen reduction and allergy at 4 yr: follow up of the PIAMA-study. | Q51162811 | ||
| Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. | Q51699174 | ||
| Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. | Q51708828 | ||
| The effect of omalizumab on nasal allergic inflammation. | Q51711184 | ||
| Rhinitis as an independent risk factor for adult-onset asthma. | Q51723774 | ||
| Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. | Q52582898 | ||
| Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. | Q52666713 | ||
| Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. | Q52930916 | ||
| A novel adjuvant complex, tyrosine-MPL, for prophylactic and therapeutic vaccines. | Q53006587 | ||
| A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. | Q53176283 | ||
| Asthma control during the year after bronchial thermoplasty. | Q53199152 | ||
| Regulatory T cells in allergy and asthma. | Q53527505 | ||
| Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation | Q28586791 | ||
| Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys | Q29615415 | ||
| Epithelium: at the interface of innate and adaptive immune responses | Q33605263 | ||
| Long-term clinical efficacy of grass-pollen immunotherapy | Q33870492 | ||
| Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy | Q34361871 | ||
| IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking | Q34391196 | ||
| Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy | Q34412092 | ||
| Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. | Q34414680 | ||
| Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity | Q34424967 | ||
| Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy | Q34569278 | ||
| Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies | Q34574834 | ||
| Role of regulatory T cells and FOXP3 in human diseases. | Q34657962 | ||
| Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts | Q34890064 | ||
| Airway remodeling in asthma: new insights | Q35067523 | ||
| IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? | Q35129625 | ||
| How do corticosteroids work in asthma? | Q35215886 | ||
| Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma | Q35537338 | ||
| IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells | Q35855291 | ||
| New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA. | Q35913535 | ||
| Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics | Q36001230 | ||
| Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. | Q36148739 | ||
| Interleukin-17 is a negative regulator of established allergic asthma | Q36228146 | ||
| Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells | Q36228688 | ||
| T-helper cell type-2 regulation in allergic disease | Q36327479 | ||
| Antisense- and RNA interference-based therapeutic strategies in allergy. | Q36346493 | ||
| Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support | Q36359466 | ||
| Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice | Q36369377 | ||
| Thymic stromal lymphopoietin: master switch for allergic inflammation | Q36375911 | ||
| Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis | Q36376986 | ||
| Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo | Q36403209 | ||
| Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus | Q36403355 | ||
| Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy. | Q36479029 | ||
| Emerging possibilities in the development and function of regulatory T cells | Q36486882 | ||
| Are phosphodiesterase 4 inhibitors just more theophylline? | Q36496374 | ||
| Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis | Q44974487 | ||
| Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis | Q45088215 | ||
| Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. | Q46424938 | ||
| A chimeric human-cat fusion protein blocks cat-induced allergy | Q46483879 | ||
| Evidence of a role of tumor necrosis factor alpha in refractory asthma | Q46947260 | ||
| Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. | Q53536137 | ||
| Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. | Q53583932 | ||
| Immunologic response to administration of standardized dog allergen extract at differing doses. | Q53583936 | ||
| Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. | Q53850475 | ||
| Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. | Q54692531 | ||
| Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. | Q55034563 | ||
| Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency | Q57085071 | ||
| Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma | Q57138398 | ||
| Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing | Q57638228 | ||
| A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract | Q57909865 | ||
| Role of deficient type III interferon-λ production in asthma exacerbations | Q57981862 | ||
| Novel Recombinant Interleukin-13 Peptide-based Vaccine Reduces Airway Allergic Inflammatory Responses in Mice | Q61823392 | ||
| Effects of adenovirus-expressing IL-10 in alleviating airway inflammation in asthma | Q64377471 | ||
| The effects of nebulized recombinant interferon-gamma in asthmatic airways | Q72412124 | ||
| Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response | Q73470671 | ||
| Evaluation of impermeable covers for bedding in patients with allergic rhinitis | Q73683115 | ||
| gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation | Q73808236 | ||
| Efficacy of soluble IL-4 receptor for the treatment of adults with asthma | Q73993404 | ||
| TNF-alpha dysregulation in asthma: relationship to ongoing corticosteroidtherapy | Q74026409 | ||
| The eosinophil--quo vadis? | Q75233238 | ||
| Growth factors as treatment options for intestinal inflammation | Q79288967 | ||
| IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells | Q79451452 | ||
| Th17 cells: An orphan with influence | Q79573341 | ||
| Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma | Q79711349 | ||
| Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study | Q79755050 | ||
| Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate | Q79826046 | ||
| Recombinant allergens for immunotherapy | Q79867962 | ||
| The safety of immunotherapy | Q79917750 | ||
| Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis | Q80125594 | ||
| New developments in FcepsilonRI regulation, function and inhibition | Q80168002 | ||
| Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children | Q80190687 | ||
| IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways | Q80209359 | ||
| Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization | Q80464491 | ||
| Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers | Q80505531 | ||
| Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents | Q80505534 | ||
| Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide | Q80736152 | ||
| Control of allergic reactions in mice by an active anti-murine IL-4 immunization | Q80843158 | ||
| Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients | Q80859940 | ||
| Exacerbations: the asthma paradox | Q81334605 | ||
| Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma | Q81339821 | ||
| Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies | Q81471173 | ||
| An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment | Q81606189 | ||
| Long-term inhaled corticosteroids in preschool children at high risk for asthma | Q83316436 | ||
| ??? | Q28185664 | ||
| The role of the mast cell in the pathophysiology of asthma | Q36496382 | ||
| Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation | Q36557250 | ||
| Distinct regulation of interleukin-17 in human T helper lymphocytes | Q36571575 | ||
| The mechanisms, diagnosis, and management of severe asthma in adults | Q36578773 | ||
| Regulation of the T cell response | Q36643790 | ||
| The asthma epidemic | Q36662046 | ||
| Sublingual immunotherapy: the optimism and the issues | Q36738270 | ||
| Role of interleukin-21 in inflammation and allergy | Q36757685 | ||
| Update on the current status of peptide immunotherapy | Q36785525 | ||
| Montelukast in the treatment of allergic rhinitis: an evidence-based review | Q36788365 | ||
| Trawling for treasure: tales of T-bet | Q36794291 | ||
| The epithelium takes centre stage in asthma and atopic dermatitis | Q36805093 | ||
| Chemokines and their receptors as potential targets for the treatment of asthma | Q36807456 | ||
| The mast cell IgG receptors and their roles in tissue inflammation | Q36819920 | ||
| Modulating leukocyte recruitment in inflammation | Q36845427 | ||
| On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis | Q36851187 | ||
| Peanut allergy: emerging concepts and approaches for an apparent epidemic | Q36906296 | ||
| Understanding allergic asthma from allergen inhalation tests | Q36975799 | ||
| 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation | Q36990620 | ||
| Prevention of allergic respiratory disease in infants: current aspects and future perspectives | Q36995981 | ||
| Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness | Q37144550 | ||
| Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study | Q39581669 | ||
| Modifications to an Fcgamma-Fcvarepsilon fusion protein alter its effectiveness in the inhibition of FcvarepsilonRI-mediated functions | Q40125121 | ||
| Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy | Q40146458 | ||
| Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects | Q40364862 | ||
| IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation | Q40427613 | ||
| Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. | Q40476204 | ||
| Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis | Q40486781 | ||
| Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis | Q40523833 | ||
| Generation of therapeutic antibody responses against IgE through vaccination | Q40584043 | ||
| Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). | Q40588482 | ||
| Transcription factors and asthma | Q40846857 | ||
| Functional KCa3.1 K+ channels are required for human lung mast cell migration | Q40985571 | ||
| Requirement for IL-13 independently of IL-4 in experimental asthma | Q41881960 | ||
| Potential masking effects of salmeterol on airway inflammation in asthma | Q42539849 | ||
| Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats | Q42615880 | ||
| Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. | Q43724345 | ||
| Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling | Q43968795 | ||
| Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process | Q44223903 | ||
| Identification of the Syk kinase inhibitor R112 by a human mast cell screen | Q44388340 | ||
| Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma | Q44534206 | ||
| Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma | Q44654747 | ||
| Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial | Q44748560 | ||
| The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells | Q44969227 | ||
| P433 | issue | 3 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 218-230 | |
| P577 | publication date | 2008-02-15 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Treatment strategies for allergy and asthma | |
| P478 | volume | 8 |
| Q28077213 | 'The Microbiome and the Pathophysiology of Asthma' |
| Q36701411 | A Cell-Impermeable Cyclosporine A Derivative Reduces Pathology in a Mouse Model of Allergic Lung Inflammation |
| Q34182028 | A beneficial role for immunoglobulin E in host defense against honeybee venom |
| Q34964763 | A genome-wide association study of total serum and mite-specific IgEs in asthma patients |
| Q36229717 | A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses. |
| Q37252613 | A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice |
| Q37599075 | Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease |
| Q38682652 | Airway Epithelial Cells Are Crucial Targets of Glucocorticoids in a Mouse Model of Allergic Asthma. |
| Q37240146 | Allergens stimulate store-operated calcium entry and cytokine production in airway epithelial cells |
| Q64248940 | Allergic Airway-Induced Hypersensitivity Is Attenuated by Bergapten in Murine Models of Inflammation |
| Q87299023 | Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice |
| Q34204432 | Allergic asthma: influence of genetic and environmental factors |
| Q34114469 | Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice |
| Q47972797 | Allergic respiratory disease: Different allergens, different symptoms |
| Q37043414 | Allergy Enhances Neurogenesis and Modulates Microglial Activation in the Hippocampus. |
| Q54942248 | Altered levels of memory T cell subsets and common γc cytokines in Strongyloides stercoralis infection and partial reversal following anthelmintic treatment. |
| Q41631408 | Alternative Macrophage Activation Is Increased in Asthma |
| Q35142804 | Aluminium in Allergies and Allergen immunotherapy |
| Q40076766 | An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice |
| Q38381344 | Anti-allergic properties of curine, a bisbenzylisoquinoline alkaloid. |
| Q36933660 | Anti-asthmatic and anxiolytic effects of Herissantia tiubae, a Brazilian medicinal plant |
| Q47233399 | Anti-inflammatory effects of embelin in A549 cells and human asthmatic airway epithelial tissues |
| Q38858992 | Antiallergic effects of peiminine through the regulation of inflammatory mediators in HMC-1 cells |
| Q38939073 | Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. |
| Q41342773 | Aquaporin-3 potentiates allergic airway inflammation in ovalbumin-induced murine asthma |
| Q36602201 | Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics |
| Q34157800 | Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye? |
| Q37885396 | Can anti-IgE therapy prevent airway remodeling in allergic asthma? |
| Q38332786 | Characterization of STAT6 target genes in human B cells and lung epithelial cells |
| Q53175575 | Chemotactic and Phagocytic Activity of Blood Neutrophils in Allergic Asthma. |
| Q34073570 | Chronic inflammation and asthma |
| Q45189641 | Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions |
| Q39527744 | Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation |
| Q36437966 | Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. |
| Q84695268 | Comparison of intradermal skin testing (IDST) and serum allergen-specific IgE determination in an experimental model of feline asthma |
| Q54213225 | Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today. |
| Q47119032 | Correlation of cutaneous sensitivity and cytokine response in children with asthma. |
| Q38108655 | Crosstalk between the circadian clock circuitry and the immune system. |
| Q37445966 | Current status and challenges of cytokine pharmacology. |
| Q47778162 | Cutaneous vaccination with coated microneedles prevents development of airway allergy |
| Q35709938 | Cytotoxic and apoptotic effects of Ebenus boissieri Barbey on human lung cancer cell line A549. |
| Q34154042 | Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma |
| Q87460655 | Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies |
| Q45064301 | Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells. |
| Q39827418 | Distinct structural requirements for interleukin-4 (IL-4) and IL-13 binding to the shared IL-13 receptor facilitate cellular tuning of cytokine responsiveness |
| Q46198285 | Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma |
| Q39592872 | Effect of Scrophularia buergeriana extract on the degranulation of mast cells and ear swelling induced by dinitrofluorobenzene in mice |
| Q47643969 | Effects of anti-inflammatory drugs on the expression of tryptophan-metabolism genes by human macrophages. |
| Q36077437 | Effects of cromolyn sodium on isolated rat's trachea. |
| Q47413246 | Effects of the inhaled treatment of liriope radix on an asthmatic mouse model |
| Q40101989 | Efficacy of a Nasal Spray from Citrus limon and Cydonia oblonga for the Treatment of Hay Fever Symptoms-A Randomized, Placebo Controlled Cross-Over Study |
| Q28260197 | Electronic cigarette use and harm reversal: emerging evidence in the lung |
| Q26741488 | Elucidating novel disease mechanisms in severe asthma |
| Q37744925 | Emerging roles of T helper subsets in the pathogenesis of asthma |
| Q89965827 | Engineered Nanomaterials and Type I Allergic Hypersensitivity Reactions |
| Q35147131 | Enhanced generation of suppressor T cells in patients with asthma taking oral contraceptives |
| Q45022851 | Enhanced glucocorticoid-induced leucine zipper in dendritic cells induces allergen-specific regulatory CD4(+) T-cells in respiratory allergies |
| Q58707417 | Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort |
| Q88244199 | Enhancing human cord blood hematopoietic stem cell engraftment by targeting nuclear hormone receptors |
| Q42578489 | Epicutaneous Immunotherapy for Aeroallergen and Food Allergy |
| Q37868794 | Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? |
| Q37612898 | Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production |
| Q52310283 | Epigenome-wide association study of total serum immunoglobulin E in children: a life course approach. |
| Q34075540 | Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility |
| Q21245454 | Evolutionary divergence and functions of the human interleukin (IL) gene family |
| Q37067033 | F-fucoidan from Saccharina japonica is a novel inducer of galectin-9 and exhibits anti-allergic activity |
| Q37395866 | Fiber-optic microsphere-based antibody array for the analysis of inflammatory cytokines in saliva |
| Q37293104 | Finding better therapeutic targets for patients with asthma: adenosine receptors? |
| Q88576669 | From allergen to oral vaccine carrier: A new face of ragweed pollen |
| Q40232460 | Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target. |
| Q50045631 | Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC |
| Q28512834 | GPR17 regulates immune pulmonary inflammation induced by house dust mites |
| Q37694606 | Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways |
| Q37829670 | Gene therapy for allergic airway diseases |
| Q37472230 | Genetics of asthma: a molecular biologist perspective |
| Q90147067 | Ginseng alleviates microbial infections of the respiratory tract: a review |
| Q53642532 | Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat. |
| Q37680540 | Harnessing regulatory T cells to suppress asthma: from potential to therapy |
| Q52693563 | Heritability and repeatability of insect bite hypersensitivity in Dutch Shetland breeding mares. |
| Q37808205 | Histamine H3 Receptor as a Drug Discovery Target |
| Q45901430 | IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation. |
| Q54117235 | IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation. |
| Q41863615 | IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease |
| Q36804221 | IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy |
| Q38844328 | IgE and mast cells in host defense against parasites and venoms |
| Q90576493 | Immunoregulatory role of acid sphingomyelinase in allergic asthma |
| Q36251520 | Inactivated influenza virus vaccine is efficient and reduces IL-4 and IL-6 in allergic asthma mice. |
| Q36109885 | Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma |
| Q33835518 | Inducing maternal inflammation promotes leptin production in offspring but does not improve allergic symptoms in a mouse model of allergic rhinitis |
| Q37404069 | Influence of subcutaneous specific immunotherapy on drug costs in children suffering from allergic asthma |
| Q33805243 | Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein. |
| Q37600200 | Innate cells and T helper 2 cell immunity in airway inflammation |
| Q28076134 | Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease |
| Q33780731 | Insulin Modulates Cytokine Release, Collagen and Mucus Secretion in Lung Remodeling of Allergic Diabetic Mice. |
| Q57808217 | Integrative Analysis of lncRNAs, miRNAs, and mRNA-Associated ceRNA Network in an Atopic Dermatitis Recurrence Model |
| Q33951731 | Interleukin-17 regulation: an attractive therapeutic approach for asthma |
| Q35661750 | Invariant Natural Killer T Cells Play a Role in Chemotaxis, Complement Activation and Mucus Production in a Mouse Model of Airway Hyperreactivity and Inflammation |
| Q47344065 | Investigation of in vitro and in vivo anti-asthmatic properties of Siphonochilus aethiopicus |
| Q54440726 | Knocking down Cav1 calcium channels implicated in Th2 cell activation prevents experimental asthma. |
| Q37740057 | Leaves of Raphanus sativus L. Shows Anti-Inflammatory Activity in LPS-Stimulated Macrophages via Suppression of COX-2 and iNOS Expression |
| Q37310879 | Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury. |
| Q38173334 | Linking GATA-3 and interleukin-13: implications in asthma |
| Q38089177 | Lipoxins, resolvins and protectins: new leads for the treatment of asthma |
| Q83400970 | Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV |
| Q63363285 | Lung NKT cell commotion takes your breath away |
| Q43663961 | MAG-EPA resolves lung inflammation in an allergic model of asthma |
| Q41112447 | Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms |
| Q26775969 | Mast cells and IgE in defense against venoms: Possible "good side" of allergy? |
| Q33590429 | Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78 |
| Q38208042 | Mechanisms of pathogenesis in allergic asthma: role of interleukin-23. |
| Q26752782 | Microwave-Assisted Synthesis of Bioactive Six-Membered Heterocycles and Their Fused Analogues |
| Q40550703 | Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance |
| Q27021418 | Modulation of specific and allergy-related immune responses by helminths |
| Q92681753 | Molecular Signature of Asthma-Enhanced Sensitivity to CuO Nanoparticle Aerosols from 3D Cell Model |
| Q43018557 | Molecular metamorphosis in polcalcin allergens by EF-hand rearrangements and domain swapping |
| Q28270037 | Monoclonal antibodies and other biologic agents in the treatment of asthma |
| Q37848219 | Monoclonal antibodies for the treatment of severe asthma |
| Q37354215 | Multiplexed salivary protein profiling for patients with respiratory diseases using fiber-optic bundles and fluorescent antibody-based microarrays. |
| Q49126149 | Murine Models of Allergic Asthma |
| Q37715475 | Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma |
| Q38828804 | NecroX-5 suppresses IgE/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module |
| Q39120608 | Neonatal bacillus Calmette-Guérin vaccination inhibits de novo allergic inflammatory response in mice via alteration of CD4+CD25+ T-regulatory cells |
| Q28818549 | Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis |
| Q99637269 | New insights into the cell- and tissue-specificity of glucocorticoid actions |
| Q33623326 | New insights into the regulation of T cells by gamma(c) family cytokines |
| Q40807077 | Novel T-cell epitopes on Schistosoma japonicum SjP40 protein and their preventive effect on allergic asthma in mice |
| Q36605117 | Nuclear matrix binding protein SMAR1 regulates T-cell differentiation and allergic airway disease |
| Q24630261 | Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity |
| Q37937557 | Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases |
| Q38201304 | Omalizumab for severe asthma: efficacy beyond the atopic patient? |
| Q38754492 | Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature. |
| Q37362658 | Omalizumab in the treatment of severe asthma: efficacy and current problems |
| Q36055963 | Omalizumab: clinical use for the management of asthma. |
| Q26740044 | Perimenstrual asthma: from pathophysiology to treatment strategies |
| Q36765753 | Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients |
| Q42246466 | Pharmacological evaluation of Apium leptophyllum (Pers.) on bronchial asthma |
| Q38157770 | Pharmacotherapy of critical asthma syndrome: current and emerging therapies |
| Q36056484 | Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform |
| Q44624657 | Potential therapy of Fc-antigen combination-encoding DNA vaccination in mouse allergic airway inflammation |
| Q50993800 | Preliminary studies on the prevention of the ovalbumin-induced allergic response by Enterococcus faecalis CECT7121 in mice. |
| Q38177218 | Preventing progression of allergic rhinitis to asthma |
| Q27331682 | Prevention of house dust mite induced allergic airways disease in mice through immune tolerance |
| Q37447495 | Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation |
| Q85100601 | Progress towards anticytokine therapy in asthma |
| Q37447476 | Protease-activated receptors and prostaglandins in inflammatory lung disease. |
| Q42114151 | Protective effects of Scrophularia striata in Ovalbumin-induced mice asthma model |
| Q57090578 | Protective effects of farming on allergies and asthma: have we learnt anything since 1873? |
| Q84007863 | Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma |
| Q36702881 | Reduction of Airway Hyperresponsiveness by KWLL in Dermatophagoides-pteronyssinus-Challenged Mice |
| Q55052500 | Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes. |
| Q30009861 | Regulation of immune responsiveness in vivo by disrupting an early T-cell signaling event using a cell-permeable peptide |
| Q43087975 | Regulatory T cells and regulation of allergic airway disease |
| Q34448487 | Resolvins: natural agonists for resolution of pulmonary inflammation. |
| Q47741693 | Respiratory sensitization: toxicological point of view on the available assays |
| Q42700018 | Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice |
| Q38534952 | Rice seed for delivery of vaccines to gut mucosal immune tissues |
| Q42150907 | Role of innate lymphocytes in infection and inflammation |
| Q92757510 | Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma |
| Q38129447 | Serum biomarkers in elderly asthma. |
| Q58604271 | Sevoflurane Inhibits the Th2 Response and NLRP3 Expression in Murine Allergic Airway Inflammation |
| Q38819684 | Sex differences in the pro-inflammatory cytokine response to endotoxin unfold in vivo but not ex vivo in healthy humans |
| Q35207683 | Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice. |
| Q36734168 | Some medicinal plants with antiasthmatic potential: a current status |
| Q38898505 | Spiraeoside inhibits mast cells activation and IgE-mediated allergic responses by suppressing phospholipase C-γ-mediated signaling |
| Q28533884 | Streptochlorin suppresses allergic dermatitis and mast cell activation via regulation of Lyn/Fyn and Syk signaling pathways in cellular and mouse models |
| Q48003554 | Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. |
| Q29302965 | Suppressive effect of Petasites japonicus extract on ovalbumin-induced airway inflammation in an asthmatic mouse model |
| Q90675937 | Surveillance of First-Generation H1-Antihistamine Use for Older Patients with Dementia in Japan: A Retrospective Cohort Study |
| Q40372154 | Systemic and mucosal pre-administration of recombinant Helicobacter pylori neutrophil-activating protein prevents ovalbumin-induced allergic asthma in mice |
| Q92538835 | T Follicular Helper Cell Subsets and the Associated Cytokine IL-21 in the Pathogenesis and Therapy of Asthma |
| Q38134677 | T helper cells plasticity in inflammation. |
| Q92647952 | TRPV4 is dispensable for the development of airway allergic asthma |
| Q34271232 | Targeting interleukin-4 in asthma: lost in translation? |
| Q38757788 | Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma |
| Q28085379 | Testing the 'toxin hypothesis of allergy': mast cells, IgE, and innate and acquired immune responses to venoms |
| Q45095885 | Th2 responses in OVA-sensitized BALB/c mice are down-modulated by Mycobacterium bovis BCG treatment. |
| Q39011698 | Th9 and other IL-9-producing cells in allergic asthma |
| Q37155054 | The Advance of Personalized and Stratified Therapies in Bronchial Asthma: Phenotypes - Endotypes - Biomarkers |
| Q40915156 | The IL-33 receptor (ST2) regulates early IL-13 production in fungus-induced allergic airway inflammation |
| Q36509214 | The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis |
| Q58589064 | The Plant Proteinase Inhibitor Plays a Role in Controlling Asthma Response in Mice |
| Q34532292 | The Potential of Anti-IgE in Food Allergy Therapy |
| Q58566763 | The Prospects of an Active Vaccine Against Asthma Targeting IL-5 |
| Q36613696 | The development of allergic inflammation |
| Q34080204 | The effect of serine protease inhibitors on airway inflammation in a chronic allergen-induced asthma mouse model. |
| Q37766451 | The many paths to asthma: phenotype shaped by innate and adaptive immunity |
| Q92491308 | The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab |
| Q33762811 | The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation |
| Q41755302 | The potential role of omalizumab in the treatment of chronic urticaria |
| Q36430741 | The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms |
| Q36462100 | Therapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM) |
| Q37550543 | Therapeutic management of allergic diseases. |
| Q38031462 | Therapeutical measures to control airway tolerance in asthma and lung cancer |
| Q55000062 | Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease. |
| Q36870120 | Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation |
| Q36328682 | Tonggyu-tang, a traditional Korean medicine, suppresses pro-inflammatory cytokine production through inhibition of MAPK and NF-κB activation in human mast cells and keratinocytes. |
| Q53142659 | Topical Application of Fingolimod Perturbs Cutaneous Inflammation. |
| Q90680348 | Topical Application of KAJD Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis Symptoms Through Regulation of IgE and MAPK Pathways in BALB/C Mice and Several Immune Cell Types |
| Q82720481 | Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice |
| Q34405154 | Toxoplasma gondii infection induces suppression in a mouse model of allergic airway inflammation |
| Q59273852 | Treatment of Allergic Rhinitis as a Strategy for Preventing Asthma |
| Q27011823 | Treatment of allergic asthma: modulation of Th2 cells and their responses |
| Q42408022 | Treatment with Mycophenolat Mofetil of Steroid-Dependent Asthma—One Case of Severe Asthma |
| Q74441372 | Treatment: In search of a booster shot |
| Q46329385 | Tripterygium polyglycosid attenuates the established airway inflammation in asthmatic mice |
| Q38096872 | Type 2 innate lymphocytes in allergic airway inflammation |
| Q36430634 | Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies |
| Q35117827 | Update on optimal use of omalizumab in management of asthma. |
| Q43193470 | Upgrading a natural product: inhibition of human beta-tryptase by cyclotheonamide analogues |
| Q37754792 | Use of biologicals as immunotherapy in asthma and related diseases |
| Q37194990 | VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis. |
| Q35204523 | Vitamin D and the development of allergic disease: how important is it? |
| Q34996190 | Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial |
| Q41778930 | Xanthii Fructus inhibits allergic response in the ovalbumin-sensitized mouse allergic rhinitis model |
| Q38932407 | microRNA and Allergy |
Search more.